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Abstract. Modelling and analysis of competing risks data with long-term survivors
is an important area of research in recent years. For example, in the study of cancer
patients treated for soft tissue sarcoma, patient may die due to different causes. Consid-
erable portion of the patients may remain cancer free after the treatment. Accordingly,
it is important to incorporate long-term survivors in the analysis of competing risks
data. Motivated by this, we propose a new method for the analysis of competing risks
data with long term survivors. The new method enables us to estimate the overall
survival probability without estimating the cure fraction. We formulate the effects of
covariates on sub-distribution (cumulative incidence) functions using linear transfor-
mation model. Estimating equations based on counting process are developed to find
the estimators of regression coefficients. The asymptotic properties of the estimators
are studied using martingale theory. An extensive Monte Carlo simulation study is
carried out to assess the finite sample performance of the proposed estimators. Fi-
nally, we illustrate our method using a real data set.
Key words: Competing risks; Counting process; Cure rate model; Linear transforma-
tion; Martingale.
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1. Introduction
Competing risks data emerge naturally in medical research when the subjects under
study are at risks for more than one cause of failure. That is, a patient experiences an
event other than the event of interest, which may change the probability of experiencing
the event of interest. For example, consider the study of patients suffering from heart
disease. The patients may die due to other causes like an accident or other diseases. The
cause specific hazard and cumulative incidence functions are commonly employed for the
analysis of competing risks data. Crowder (1997), Kalbfleisch and Prentice (2002) and
Lawless (2002) have given a comprehensive review on this topic.
In lifetime studies, researchers generally assume that all of the study subjects
will experience the event of interest, if they are followed long enough. However, in some
situations a non-negligible proportion of individuals may not experience the event of
interest even after a long period of time. For example, in clinical trials, there exist
a proportion of subjects who may not experience such an event. These patients may
not be treated as censored individuals, and should be considered as cured. Traditional
methods for analyzing survival data has to be modified to incorporate survival data
with cure fraction. Cure rate models have a wide range of applications in many fields
including medical and public health, especially in cancer studies. In cure rate models, the
entire population is considered as a mixture of two groups of patients, susceptible (non-
cured) and non-susceptible (cured). In clinical trials of cancer studies the proportion of
cured individuals is an important measure in estimating survival probabilities of patients
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suffering from cancer. Hence it is important to develop models which incorporates cure
fraction.
The mixture cure rate model (MCM) proposed by Boag (1949) has been popular
in the analysis of survival data with long term survivors. For various properties and
analysis of lifetime data using the mixture model one may refer to Farewell (1982),
Taylor (1995), Peng and Dear (2000), Banerjee and Carlin (2004) and Zhang and Peng
(2007) among others. The books by Maller and Zhou (1996) and Ibrahim, Chen and
Sinha (2002) were served as excellent references on this topic.
When the population is comprised of both cured and non-cured group of indi-
viduals, and the non-cured group is exposed to different risks we have access to compet-
ing risks data with a cure fraction of subjects. For example, consider the data obtained
from a clinical trial on HIV infection and AIDS of 329 homosexual men from Amsterdam
reported in Geskus (2015). During the course of period from HIV infection (NSI pheno-
type) to death, the virus may be switched to SI phenotype or AIDS; which are mutually
exclusive events and both affect the subsequent disease progression differently. Hence
it is important to observe which infection has occurred first. The presence or absence
of the CCR5-∆32 deletion in one or both chromosomes is considered as the covariate in
the study. An interesting characteristic of the data is that time of occurrence of these
events vary from 0.112 years (approximately 41days) to 13.936 years (approximately
5090 days). We also found that after 12.4 years (4526 days) there are only 3 events ob-
served (one due to AIDS and two due to SI), whereas around 14.5% of the total lifetimes
reported are larger than 12.4 years. High number of largest observations are censored
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in the data suggest the possible presences of cured individuals (Maller and Zhao, 1996)
and it became intuitive to analyse the data using cure rate model with competing risks.
In Section 5, we use this data to illustrate the applicability of the proposed method.
Modeling and analysis of competing risks data with cure fraction is considered
by several authors in literature. A Bayesian method that unifies the mixture cure and
competing risks approaches is developed by Basu and Tiwari (2010). Choi, Huang, and
Cromier (2015) proposed a semiparametric mixture model to analyse competing risks
data with a cure fraction using a multinomial logistic model. A semiparametric accel-
erated failure time models for the cause-conditional survival function that is combined
through a multinomial logistic model within the cure-mixture modeling framework is de-
veloped by Choi, Zhu and Huang (2018). The vertical modeling approach is extented to
analyse competing risks data with cure fraction by Nicolaie, Taylor and Legrand (2019).
Recently, Wang, Zhang and Tang (2019) have proposed a semiparametric estimation
procedure for the accelerated failure time mixture cure model in the presence of compet-
ing risks. However, in all of these studies and other related works, one needs to estimate
the probability of failure due to each cause in the presence of covariates in advance,
mostly by a logistic regression model (Farewell, 1982), which leads to the estimation of
overall survival function.
Motivated by this, in the present study, we propose a semi-parametric regression
model to analyse competing risks data with cured individuals. Standard approaches for
analysing competing risks data is to estimate the cause specific hazard rate for each cause
or to model the cumulative incidence function (Fine and Gray, 1999). Another method
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for analysing the competing risks data is the finite mixture model where we assumes
that the population under consideration is a mixture of subjects whose failure types are
classified into one of the causes of failure (Choi and Huang, 2014). We use mixture
model approach to to analyse the competing risks data with cure fraction. We model
cumulative incidence functions of the competing risks data using linear transformation.
Unlike the traditional approach discussed earlier, the novelty of our approach is that we
can estimate the overall survival function without estimating the cure fraction separately.
This achievement is in the line of promotion time cure model discussed by Tsodikov
(2002) in the non-competing risks scenario.
The rest of the article is organized as follows. In Section 2, we propose a
semiparametric model for the analysis of competing risks data with cure fraction. In
Section 3, we develop counting process based estimating equations to find the estimators
of regression coefficients. The asymptotic properties of the estimators are also studied.
An extensive Monte Carlo simulation study is carried out to assess the finite sample
performance of the proposed estimators. Computational algorithms along with the re-
sults of the simulation study are presented in Section 4. In Section 5, we illustrate the
application of the proposed method using a real data set obtained from a study of HIV
and AIDS infection. Finally, in Section 6, we summarise major conclusions of the study
along with discussion on some open problems.
2. Model and methods
Suppose each subjects/patient may experiences one of the K distinct failure types. Let
(T, J) be the competing risks data, where T denotes the time to first event, and J ∈
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{0, 1, ,K}, where J = k, k = 1, . . . ,K indicates that a patient fails due to one of the
k-th causes. We use the value J = 0 to denote the sub group of patients who are
insusceptible to any type of the diseases. The mixture modeling approach has been
popular in the analysis of lifetime data with long term survivors. In the presence of cure
fraction, mixture model of competing risks data assumes that the failure time T can be
decomposed as
T =
K∑
k=1
Tk.I(J = k) +∞.I(J = 0),
where the latent variables Tk denote the failure time due to cause k, k = 1, . . . ,K.
Let Z be p-dimensional covariates possibly time variant. We assume that the
censoring random C is independent of T , conditional on the covariates Z. Also let X
be another time-independent covariates that may have some common elements with Z.
Denote pik(θ) = P (J = k|X) is the probability of experiencing the event from cause
k, k = 0, 1, . . . ,K. Under the finite-mixture model, practitioners usually estimate pik(θ)
by modeling it as logistic distribution given by (Farewell, 1982)
pik(θ) =
exp(X ′θk)
1 + exp(X ′θk)
, k = 1, . . .K,
where θk is a collection of parameter vectors and pi0(θ) = 1−
∑K
k=1 pik(θ). Mixture cure
rate model assumes that the overall conditional survival function of T given Z has the
representation given by
S(t, ν) = P (T > t|Z,X) = pi0(θ) +
K∑
k=1
pik(θ)Sk(t|β, Z), (1)
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where Sk(t|β, Z) = P (Tk > t|J = k, Z) and ν = {(θk, βk), k = 1, . . . ,K} denotes the full
set of parameters. To estimate S(t, ν) specified in Eq. (1), we need to model the effect
of covariates on the cure rate of the population and the survival function of the non-
susceptible subjects separately. This makes the implementation of the method complex
and computationally challenging. Motivated by this, we propose a new method to anal-
yse the competing risks data with long term survivors. We consider a semi-parametric
transformation model for cumulative incidence function, which is the probability of fail-
ure from any one cause over a certain time period in the presence of other risks.
Now we express S(t, ν) given in Eq. (1) in terms of the conditional sub-
distribution function Fk(t, J |Z) = P (T ≤ t, J = k|Z). Consider
Fk(t, J |Z) = P (T ≤ t, J = k|Z)
= P (T ≤ t|J = k, Z)P (J = k|Z)
= (1− P (T > t|J = k, Z))P (J = k|Z)
= pik(θ)(1− Sk(t|β, Z)). (2)
The representation given in Eq. (2) allows us to model the conditional sub-distribution
function through pik(θ). We use linear transformation models to specify each sub-
distribution function Fk(t, J |Z) without using pik(θ). Thus, using Eq. (2), we rewrite
S(t, ν) given in Eq. (1) as
S(t, ν) = 1−
K∑
k=1
Fk(t, J |Z). (3)
8 Sudheesh. K. K., Sreedevi. E. P. and Sankaran. P. G.
In the proposed method, we formulate each conditional sub-distribution func-
tion Fk(t, J |Z) in Eq. (3) through a class of linear transformation models specified by
(Mao and Lin, 2017)
gk{Fk(t, J |Z)} = hk(t) + Z ′βk, k = 1, 2, . . . ,K, (4)
where gk is a known increasing cause specific link function, hk(t) is an unknown non-
decreasing function of time and βk is a set of regression parameters. The proportional
sub-distribution hazards model and proportional odds model are special cases of (4)
when gk(x) takes the form log(− log(1− x)) and log(x/(1− x)), respectively. For more
details on linear transformation model we refer interested readers to Doksum (1987),
Chen, Jin and Ying (2002), Zeng and Lin (2006) and Mao and Lin (2017).
From Eq. (4) we have
Fk(t, J |Z) = g−1k (hk(t) + Z ′βk), k = 1, 2, . . . ,K. (5)
Thus, using Eq. (3), the conditional survival function of T given Z is given by
S(t, ν) = 1−
K∑
k=1
g−1k (hk(t) + Z
′βk). (6)
From the representation (6) it is clear that we can find the overall survival function of
T without estimating the cure fraction. The estimations procedures of βk and hk are
discussed in the next section.
LT MODEL FOR COMPETING RISKS DATA WITH CURE FRACTION 9
3. Estimating equation and asymptotic properties
Let T and C be the failure time and the censoring random variables. We observe T˜
and δ with T˜ = min(T,C) and δ = I(T < C) where I denote the indicator function.
Let J be a discrete random variable with support {0, 1, . . . ,K}. We assume that the
failure of a subject is due to any of the causes {1, 2, . . . ,K} and we use the notation
J = 0 to denote the subject which are insusceptible to any type of the K causes. Let
Z be p-dimensional covariates. The observed data (T˜i, δi, δiJi, Zi), i = 1, 2, . . . , n, is the
independent copies of the vector (T˜ , δ, δJ, Z). Let λk(t) and Λk(t), k = 1, . . . ,K be the
conditional cause specific hazard function and cause specific cumulative hazard function
corresponding to k-th cause.
To estimate βk and hk(.), k = 1, . . . ,K we propose the estimating equations
based on counting process. Let Nik(t) = δi.I(T˜i ≤ t, J = k) be the counting process asso-
ciated with failure time of i-th subject due to cause k, k = 1, . . . ,K and i = 1, 2, . . . , n.
Let Nk(t) =
∑n
i=1Nik(t) be the number of failure due to cause k by time t. Then
N(t) =
∑K
k=1Nk(t) is the total number of events experienced by the time t. Define
at-risk process Yi(t) = I(T˜i > t) and Y (t) =
∑n
i=1 Yi(t). It can be easily verified that
Nik(t), i = 1, . . . , n and k = 1, . . . ,K are local sub-martingales with respect to appropri-
ate filtration. Hence by Doob-Meyer decomposition, martingale process associated with
Nik(t) are given by (Andersen et al., 1993)
Mik(t) = Nik(t)−
∫ t
0
Yi(t)dΛk(t|Z), i = 1, . . . , n, k = 1, 2, . . . ,K.
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Using linear transformation model we have
Mik(t) = Nik(t)−
∫ t
0
Yi(t)dΛk(hk(t) + Z
′βk). (7)
By definition, Mik(t) is a mean zero martingale process with respect to appropriate fil-
tration (Andersen and Gill, 1982). Hence, we propose the following estimating equations
to obtain the estimators of βk and hk, k = 1, 2, . . . ,K,
Uβk(βk, hk) =
n∑
i=1
∫ ∞
0
Zi
[
dNik(u)− Yi(u)dΛk(hk(t) + Z ′iβk)
]
= 0, (8)
and
Uhk(βk, hk) =
n∑
i=1
[
dNik(t)− Yi(t)dΛk(hk(t) + Z ′βk)
]
= 0, t ≥ 0. (9)
Solving the above two equations iteratively we obtain the estimators of βk and hk,
k = 1, 2, . . . ,K. These estimating equations (8) and (9) reduces to the estimating
equation given by Chen et al. (2002) when the failure is due to only one cause.
Once the estimators of βk and hk(t) are available one can estimate the overall
survival function without estimating probability of cure. However, our newly proposed
method enables us to estimate the cured probability from the proposed model itself. We
use Eq. (5) to estimate the cure fraction. By definition (see page 348 of Lawless (2002)),
P (J = k|Z) = Fk(∞, J = k|Z) = g−1k (hk(∞) + Z ′βk).
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Thus the cure fraction is estimated using the equation given by
pi0 = 1−
K∑
k=1
g−1k (ĥk(∞) + Z ′β̂k). (10)
In practice, hk(∞) can be estimated by max(ĥk(t)).
We now provide the asymptotic distribution of the β̂k. To find the distribution
of β̂k, first we show that each ĥk is a consistent estimator of hk. Hence we use the esti-
mating equation (8) to find the asymptotic distribution of β̂k. We assume the following
regularity conditions to prove the asymptotic properties.
D1. The covariates Z are bounded in probability.
D2. The true value of the parameters βk, k = 1, . . . ,K lies in a compact set of R
p
D3. For any τ > 0 we have P (T˜ (τ) = 1) > 0, P (T > τ) > 0 and P (C ≥ τ) > 0.
D4. The derivatives of λk(.), k = 1, . . . ,K exists and continuous.
D5. The martingales defined in equation (7) satisfies the regularity conditions as in
Fleming and Harrington (1991).
The conditions D1 − D4 are standard regularity conditions used in survival analysis.
The assumption D5 is used to establish martingale central limit theorem.
Some additional notations are needed for deriving asymptotic distribution. For
any s < t ∈ (0, τ ], define
Bk(t, s) = exp
(∫ t
s
E[∂λk/∂t(Z
′
iβk0 + hk0(u))Y (u)]
E[λk(Z
′
iβk0 + hk0(u))Y (u)]
dhk0(u)
)
.
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For k = 1, . . . ,K, define µk(t) =
Czk(t)
Cdk(t)
where
Czk(t) = E[Zλk(Z
′βk0 + hk0(t))Y (t)Bk(t, T )]
and
Cdk(t) = E[λk(Z
′βk0 + hk0(t))Y (t)].
Next we state the asymptotic properties of the regression estimators and proofs
are given in Appendix A.
Theorem 1. Under the regularity conditions D1−D4, for k = 1, . . . ,K, β̂k, and ĥk are
consistent estimator of βk and hk, respectively.
Theorem 2. Under the regularity conditions D1 − D4, for k = 1, . . . ,K as n → ∞,
the distribution of
√
n(β̂k − βk) is multivariate normal with mean zero and variance
covariance matrix Σk where Σk = Σ
−1
1k Σ0k(Σ
−1
1k )
′ with
Σ0k =
∫ τ
0
E{(Z − µk(t))′(Z − µk(t))Y (t)dΛk[Z ′iβk0 + hk0(t)]} (11)
Σ1k =
∫ τ
0
E{(Z − µk(t))′Z ′∂λk/∂t{Z ′iβk0 + hk0(t)}Y (t)}dhk0(t). (12)
4. Computational Algorithm and Simulations
The estimators β̂k and ĥk are obtained as the solutions of the equations (8)
and (9). The value of ĥk are estimated at observed failure time due to the cause k. For
computational simplicity we express the set of equations (9) in an alternative form. Let
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tk1, tk2, . . . , tkm be the observed failure times due to the cause k, k = 1, 2, . . . ,K. Then
(9) can be rewritten as
n∑
i=1
Yi(tk1)Λk(Z
′
iβk + hk(tk1)) = 1, (13)
n∑
i=1
Yi(tkj)
(
Λk(hk(tkj) + Z
′
iβk)− Λ(h(tkj−) + Z ′iβk)
)
= 1, j = 2, 3, . . . ,m. (14)
Thus we have the following iterative algorithms for computing β̂k and ĥk.
Step 1. Choose an initial value βk0 for βk, k = 1, . . . ,K. Obtain an estimator ĥk for hk
by solving the equations (13) and (14).
Step 2. Find β̂k by solving the equations (8) using ĥk obtained in Step 2.
Step 3. Set βk0 = β̂k (the estimator obtained in the previous step) and repeat the Steps
1-3 until the convergence of β̂k.
To assess the finite sample performance of the proposed estimators of regression coef-
ficients, we carried out an extensive Monte Carlo simulation study using two models
where the cause specific hazard function is specified by λk(t) =
et
1+ret , r = 0, 1, k = 1, 2
and hk(T ) = log Tk. Here, r = 0, 1 corresponds to the proportional hazards and the
proportional odds model, respectively.
The covariate Z1 is generated from Bernoulli distribution with probability
of success equal to 0.5. When r = 0, we generated T using the model expression
− log(U) exp(−Z1bk), where U is U(0, 1) random variable. Also, when r = 1, T is gen-
erated from the model
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(1− U)/U) exp(−Z1bk). For generating T we set the values of parameters as (β1, β2) =
(1, 1), (1, 2), (2, 1), (2, 2). Censoring random variable C is simulated from U(0, c) dis-
tribution where c is chosen so that the simulated sample contain desired percentage
of censored observations, ie. P (T > C) = p, 0 ≤ p < 1. We consider two different
censoring scenarios with p = 0.2, 0.4. We simulated observations of different samples
sizes n = 100, 200, 500 and simulation is repeated ten thousand times. The simulation
is carried out using R program. The regression parameters are estimated using the it-
erative algorithm given in the beginning of this section. The absolute bias and MSE of
the estimators of regression coefficients obtained under PH and PO models for different
parameter settings are tabulated in Tables 1-4. From Tables 1-4 we observe that the
absolute bias of the estimators of regression coefficients approaches zero as sample size
increases. In all cases, the MSE also decreases as sample size increases. We also noted
that the absolute bias and MSE of the estimators increase with the censoring percentage.
Table 1. Absolute bias and MSE of the estimators of regression coef-
ficients under PH model
β1 = 1 β2 = 1 β1 = 1 β2 = 2
Censoring(%) n Bias1 MSE1 Bias2 MSE2 Bias1 MSE1 Bias2 MSE2
20
100 0.0290 0.2652 0.0174 0.3994 0.0373 0.2680 0.0263 0.4008
200 0.0041 0.1810 0.0103 0.2774 0.0041 0.2041 0.0054 0.2922
500 0.0053 0.1135 0.0065 0.1593 0.0039 0.1172 0.0088 0.1746
40
100 0.0232 0.4576 0.0210 0.4790 0.0510 0.4999 0.0350 0.4635
200 0.0341 0.3354 0.0065 0.3188 0.0061 0.3310 0.0225 0.3316
500 0.0043 0.1998 0.0027 0.2065 0.0045 0.1895 0.0112 0.2035
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Table 2. Absolute bias and MSE of the estimators of regression coef-
ficients under PH model
β1 = 2 β2 = 1 β1 = 2 β2 = 2
Censoring(%) n Bias1 MSE1 Bias2 MSE2 Bias1 MSE1 Bias2 MSE2
20
100 0.0517 0.2667 0.0398 0.4095 0.0270 0.2864 0.0232 0.3782
200 0.0092 0.1236 0.0099 0.2408 0.0176 0.1823 0.0174 0.2789
500 0.0062 0.0733 0.0064 0.1539 0.0056 0.1205 0.0041 0.1764
40
100 0.0546 0.4580 0.0410 0.4591 0.0400 0.4619 0.0325 0.4627
200 0.0290 0.3097 0.0116 0.3248 0.0270 0.3128 0.0217 0.3301
500 0.0063 0.1910 0.0102 0.2020 0.0111 0.2023 0.0090 0.2126
Table 3. Absolute bias and MSE of the estimators of regression coef-
ficients under PO model
β1 = 1 β2 = 1 β1 = 1 β2 = 2
Censoring(%) n Bias1 MSE1 Bias2 MSE2 Bias1 MSE1 Bias2 MSE2
20
100 0.0290 0.2900 0.0279 0.4088 0.0199 0.2344 0.0322 0.3899
200 0.0193 0.2091 0.0131 0.2744 0.0100 0.1902 0.0112 0.2930
500 0.0090 0.1109 0.0090 0.1812 0.0039 0.1290 0.0092 0.1923
40
100 0.0348 0.3902 0.0399 0.4503 0.0178 0.4190 0.0394 0.4578
200 0.0229 0.3099 0.0226 0.3023 0.0120 0.3467 0.0200 0.3201
500 0.0190 0.2094 0.0190 0.2101 0.0051 0.2040 0.0130 0.2100
Table 4. Absolute bias and MSE of the estimators of regression coef-
ficients under PO model
β1 = 2 β2 = 1 β1 = 2 β2 = 2
Censoring(%) n Bias1 MSE1 Bias2 MSE2 Bias1 MSE1 Bias2 MSE2
20
100 0.0421 0.2788 0.0499 0.4129 0.0289 0.2765 0.0290 0.3683
200 0.0101 0.1483 0.0199 0.2601 0.0119 0.1827 0.0199 0.2689
500 0.0078 0.0899 0.0098 0.1672 0.0056 0.1301 0.0068 0.1899
40
100 0.0499 0.4889 0.0399 0.4419 0.0568 0.4518 0.3101 0.4581
200 0.0190 0.2878 0.0238 0.3184 0.0274 0.3290 0.0289 0.3291
500 0.0099 0.2094 0.0188 0.2101 0.0190 0.2310 0.0092 0.2290
5. An example
In this section, we apply our proposed method to the data obtained from a
clinical trial on HIV infection and AIDS of 329 homosexual men from Amsterdam.
The data is available in R package mstate and is exclusively studied by Geskus (2015).
During the course from HIV infection from non-syncytium-inducing (NSI) phenotype
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to death, intermediate events may occur that have an impact on subsequent disease
progression. One such event is a switch of the HIV virus to the syncytium inducing (SI)
phenotype and the other is the progression to AIDS. Since neither of the events is final
and changes the probability of relapse/ survival of a patient, it is of interest to know
whether AIDS or SI is the first event to occur. As mentioned in the introductory section,
the data may contain cured individuals. Accordingly, we use this data to illustrate our
newly proposed method. We use the estimating equation (8) for finding the estimators
of regression coefficients. We estimate cumulative incidence functions for patients with
AIDS and SI using proportional hazard (PH) model and proportional odds (PO) models.
The presence or absence of the CCR5-∆32 deletion in one or both chromosomes
affect the progression to AIDS or SI significantly, it is considered as the covariate in this
study. Also this is the only available covariate in the data. Individuals without the
deletion of one of the chromosome are referred to as WW (wild type allele on both
chromosomes) and those who have the deletion are considered as having a mutation and
referred to as WM (mutant allele on one chromosome). Covariate values for 5 patients
are missing. We deleted them from our analysis. Out of 324 patients for 113 patients
AIDS was the first event to occur and for 107 patients the first event to occur was SI.
The remaining 104 patients are observed to be event free in the study period. For 259
patients the covariate value is WW and for the remaining 65 patients it is WM. An
interesting characteristic of the data is that, time to occurrence of event vary from 0.112
years (approximately 41days) to 13.936 years (approximately 5090 days). We also see
that after 12.4 years (4526 days) there are only 3 event times are observed one due to
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AIDS and two with the cause SI, whereas around 14.5% of the total lifetimes are larger
than 12.4 years. Presence of a large number of right censored observations indicates
the possible presence of cured individuals in the population. This fact motivates us to
analyse the data using the proposed method.
The regression coefficients are estimated using the estimating equations (8)
under PH and PO model assumption. The estimated regression coefficients with cor-
responding standard errors are reported in Table 5. To understand how the covariates
values affect the lifetimes due to different causes, we plot the cumulative incidence func-
tions due to AIDS and SI for two covariates WM and WW separately. The cumulative
incidence functions, estimated under PH and PO models are plotted in Figure 1. In
Figure 1, black colour line represents the CIF estimated using the PH model and blue
colour line denotes the same estimated using the PO model. Cure fraction is estimated
using Eq. (10). The value of cure fraction obtained using PH and PO models are 0.11
and 0.13, respectively. This estimated value of cure fraction also supports our claim that
the data consist of cured individuals.
We observed that the regression parameters are estimated differently under
proportional hazards and proportional odds model assumption. This lead to the esti-
mation of the cumulative incidence function differently. Patients with covariate ‘WW’
experience higher mortality than patients with covariate ‘WM’ under PH model, while
this pattern is not strictly followed when we consider PO model. This shows the impor-
tance of the model selection in the semiparametric analysis of competing risks data with
long term survivors.
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Table 5. Estimates of the regression parameters with corresponding
standard error
Cause Model Coefficient SE P-value
AIDS PH 0.057 0.204 0.277
PO 0.081 0.299 0.285
SI PH 0.351 0.257 0.171
PO 0.353 0.324 0.176
Figure 1. CIF of patients with AIDS and SI fitted using PH and PO models
6. Concluding Remarks
Cure rate models become very popular due to its applicability in medical stud-
ies. In the present study, we proposed a semiparametric model for the analysis of com-
peting risks data with cure fraction. We developed estimators of cumulative incidence
functions using linear transformation models. Unlike the traditional approach we do
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not want to find the estimator of the cure fraction to compute the overall survival func-
tion, which lead to simple procedure. The regression parameters are estimated using
martingale based estimating equations. The asymptotic distribution of the estimators
were shown to be Gaussian. The finite sample performance of the estimators in term of
bias and MSE was studied through Monte Carlo simulation. A real data set obtained
from a study of HIV and AIDS infection was analysed using the proposed method. The
new method developed should have a good impact in medical research due to the model
flexibility and computational advantages.
In the present study, we considered right censored data. Different types of
censoring such as current status censoring, double censoring and interval censoring are
common in survival studies. The proposed method can be extended to such set up by
suitably constructing martingale based estimating equations. The works in this direction
will be reported elsewhere. The model selection is an important criterion in analysing
competing risks data with cure fraction when we specify the cumulative incidence func-
tions through linear transformation models. One may use martingale based residual for
developing criterion for model selection. This problem also can be addressed as future
works.
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Appendix A.
A.1. Proof of Theorem 1: Let F̂k(t, J |Z)), k = 1, . . . ,K be the estimator of Fk(t, J |Z))
obtained by substituting the estimators β̂k and ĥk in (5). In cure rate model we know
that limt→∞ S(t, ν) = a0 > 0. Hence in view of the relation (3) we have lim inf(1 −∑K
k=1 F̂k(t, J |Z)) > 0. The estimators β̂k and ĥk are obtained by solving the equations
(8), (13) and (14). Hence, in view of the assumption hk(0) = −∞, and since hk is
non-decreasing function, from these three equations we can see that Λ̂k(τ) <∞, where
τ is defined in Assumption D3. Therefore, the consistency of the estimators β̂k and
Λ̂k follows from Theorem 1 of Mao and Lin (2017). Hence, by Steps A1 of Chen et al.
(2002, p.665) we have consistency of ĥk, which complete the proof of the theorem.
A.2. Proof of Theorem 2: We use martingale central limit theorem to establish the
asymptotic normality of β̂k, k = 1, . . . ,K. As we modelled each sub-distribution function
F̂k(t, J |Z) using linear transformation model, some representations given in Chen et al.
(2002) is useful for proving the asymptotic normality of β̂k.
First we represents U(β̂k, ĥk) as
U
(
β̂k, ĥk
)− U(βk, ĥk)+ (β̂k − βk) ∂
∂β
U
(
βk, ĥk
)
β=β0
.
Since U(β̂k, ĥk) = 0, we can write
√
n(β̂k − βk) = ( 1
n
∂
∂β
U
(
βk, ĥk
)
β=β0
)−1
1√
n
U
(
βk, ĥk
)
. (15)
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To establish the asymptotic normality of
√
n(β̂k−βk), we show that ( 1n ∂∂βU
(
βk, ĥk
)
β=β0
)−1
converges in probability to Σ1k (Eq. (12)) and
1√
n
U
(
βk, ĥk
)
converges in distribution
to Gaussian. Then the asymptotic normality of
√
n(β̂k − βk) follows from Slutsky’s
theorem.
Using the similar argument of Step A3 of Chen et al. (2002), we have
1
n
∂
∂β
U
(
βk, ĥk
)
β=β0
= Σ1k + op(1).
Using the martingale representation given in (7), and Step A4 of Chen et al. (2002), we
have
1√
n
U
(
βk, ĥk
)
=
1√
n
n∑
i=1
∫ τ
0
(Z − µk(t))dMik(t) + op(1).
Using martingale central limit theorem, 1√
n
U
(
βk, ĥk
)
converges in distribution to multi-
variate normal with mean vector zero and variance covariance matrix Σ0k, where Σ0k is
the limit of the predictable variation process. The predictable variation process is given
by
Σ∗0k =
1
n
n∑
i=1
∫ τ
0
(Z − µk(t))′(Z − µk(t))Y (t)dΛik(Z ′β0k + h0k(t)).
By law of large numbers, as n → ∞, Σ∗0k converges in probability to Σ0k, where Σ0k
is as specified in (11). Hence using the representation (15) and Slutsky’s theorem, as
n→∞, √n(β̂k − βk) converges in distribution to multivariate normal with mean vector
zero and variance covariance matrix Σk = Σ
−1
1k Σ0k(Σ
−1
1k )
′. This completes the proof of
Theorem 2.
